Nanotechnology Now - Press Release: "Arrowhead to Present at Rodman & Renshaw Annual Global Investment Conference"

Home > Press > Arrowhead to Present at Rodman & Renshaw Annual Global Investment Conference

Abstract:
Arrowhead Research Corporation (ARWR 0.96, -0.04, -3.88%) today announced that Dr. Christopher Anzalone, Chief Executive Officer, will be presenting at the Rodman & Renshaw Annual Global Investment Conference at 5:45 p.m. EDT on Tuesday, September 14, 2010, at the Palace Hotel in New York, NY. Dr. Anzalone will be discussing the Company and its increased focus on its nanomedicine portfolio, including clinical results.

Arrowhead to Present at Rodman & Renshaw Annual Global Investment Conference

Pasadena, CA | Posted on September 9th, 2010

Professional investors attending the conference are encouraged to schedule a one-on-one meeting with management by emailing

The presentation will be webcast live and is available for viewing at Arrowhead's website at www.arrowheadresearch.com under the "Investor Relations" section by selecting the "Presentations and Events," tab. An archive of the presentation will be available for 90 days following the conference.

Arrowhead recommends registering at least 10 minutes prior to the start of the presentation to ensure timely access.

####

About Arrowhead Research Corporation
Arrowhead Research Corporation (ARWR 0.96, -0.04, -3.88%) is a nanotechnology company commercializing new technologies in the areas of life sciences and electronics. Arrowhead is seeking to build value for shareholders through the progress of its subsidiaries and investments. Currently, Arrowhead is focused primarily on its two majority owned subsidiaries; Unidym, a leader in carbon nanotube technology for electronic applications, and Calando, at the forefront of clinical application of RNAi delivery technology. Arrowhead also has minority investments in two privately held nanobiotech companies.

For more information, please click here

Contacts:
The Piacente Group
Brandi Floberg
212-481-2050

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: